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RAGE is a multiligand receptor of the immunoglobulin superfamily involved in regeneration of injured peripheral nerve and cell motility.
RAGE is implicated in the development of various chronic diseases, such as neurodegenerative disorders, inflammatory responses, and
diabetic complications. The correlation between RAGE endocytic trafficking and RAGE function is still uninvestigated. S100B is one of the
ligands of RAGE. The molecular mechanisms responsible of S100B translocation in exocytic vesicles are still poorly investigated. In the
present study we elucidate the role of RAGE endocytic trafficking in promoting S100B secretion in Schwann cells. Here we show that
RAGE-induced secretion of S100B requires phosphorylated caveolin1-dependent endocytosis of RAGE. Endocytosis of RAGE in
response to ligand binding promotes the fusion of endosomes with S100B-positive secretory vesicles. Src promotes the fusion of
endosomes with S100B-secretory vesicles. Inhibition of src induces RAGE degradation. RAGE-mediated src activation induces cav1
phosphorylation and relocalization in the perinuclear compartment. RAGE signaling and recycling are required for S100-induced Schwann
cells morphological changes and are inhibited by high-glucose, suggesting a possible link between diabetes and peripheral nerve injury.
Indeed, high glucose inhibits RAGE-mediated src activation. Src inhibition blocks RAGE recycling, S100B secretion, and morphological
changes. In summary, we identified a novel pathway of vesicular trafficking required for the amplification of RAGE signaling and
cytoskeleton dynamics that is potentially involved in the regeneration of injured peripheral nerve.
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DOI: 10.1002/jcp.21474RAGE is a multiligand receptor of the immunoglobulin
superfamily of cell surface molecules. RAGE ligands include
AGEs, S100/calgranulins, HMGB1, amyloid-b peptides, and the
family of b-sheets fibrils (Bierhaus et al., 2005). Amplification of
RAGE-mediated signaling is implicated in the development of
such chronic diseases as neurodegenerative disorders,
inflammatory responses, and diabetic complications (Bierhaus
et al., 2005; Vincent et al., 2007). RAGE also exerts physiological
functions and its activity is required during regeneration of
injured peripheral nerves (Rong et al., 2004a,b). Schwann cells
(SC) are involved in the repair of nerve fibers (Dobrowsky et al.,
2005) and in diabetic neuropathy (Kalichman et al., 1998).
However, thus far, no study has addressed RAGE-mediated
function in SC.
Although several studies have analyzed RAGE–mediated
signaling (Bierhaus et al., 2005), the link between RAGE
activation and RAGE endocytic trafficking has been poorly
investigated. There is just one study showing that interaction of
the amyloid-b peptide (Ab) with RAGE in vascular endothelial
cells leads to transport of Ab across the blood-brain barrier
thereby inducing the expression of pro-inflammatory cytokines
(Deane et al., 2003).
The members of the S100 protein family lack the classical
signal sequence for secretion. Thus, different S100 proteins use
distinct translocation pathways. Translocation of S100B in
vesicles plays an important role in the assembly of signaling
complexes that activate specific signaling pathways (Davey
et al., 2001). Interestingly, S100B relocates from cytosol to
vesicles and induces cell motility (Mbele et al., 2002). However,
the molecular mechanisms responsible for S100B translocation
in vesicles have yet to be completely elucidated. 2 0 0 8 W I L E Y - L I S S , I N C .Recent studies have examined the role of RAGE in cell
migration (Reddy et al., 2006; Riuzzi et al., 2006; Chavakis et al.,
2007; Dumitriu et al., 2007; Orlova et al., 2007; Yang et al.,
2007) and in the dynamics of actin cytoskeleton (Dumitriu et al.,
2007). Both cell migration and changes in cell morphology
require actin polymerization together with focal adhesion
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Dynamins exert a key function in modulating the dynamics of
adhesion during migration and morphological changes, and
dynamin is implicated in both clathrin-coated pits-mediated and
caveolae-mediated endocytosis (Kruchten and McNiven,
2006). Phosphorylation and dephosphorylation of focal
adhesion kinase (Fak) is important for the turnover of focal
adhesion and subsequent reorganization of the actin
cytoskeleton necessary for cellular movement (Kruchten and
McNiven, 2006). By interacting with Fak, dyn2 is necessary for
focal adhesion turnover (Kruchten and McNiven, 2006).
Cytoskeletal and morphological changes are important for SC
differentiation, which leads to myelinization of nervous fibers
(Berti et al., 2006).
Given the relevance of endocytic trafficking in the
receptor-mediated response, the role of RAGE and SC in the
repair of injured nerves and in the development of neuropathy,
and the lack of studies in these areas, we examined the
endocytic trafficking of RAGE in SC. We demonstrate that
endocytosis of RAGE in response to ligand binding promotes
the fusion of endosomes with S100B-positive secretory
vesicles. Fusion of endosomes with S100B-secretory vesicles is
regulated by src. RAGE activation leads also to translocation of
phosphorylated cav1 in the perinuclear compartment, where it
co-localizes with dyn. We also show that RAGE triggering
induces Fak activation and SC morphological changes.
Interestingly, RAGE-induced src activation and SC
morphological changes are inhibited by high glucose (HG)
concentrations, thereby suggesting a molecular mechanism
whereby the repair of injured nerves is delayed in diabetes.
Materials and Methods
Reagents
Cell culture reagents were purchased from GIBCO BRL
(Invitrogen Corporation, Carlsbad, CA). NHS-LC-biotin,
NHS-SS-biotin, Neutravidin beads, and HRP-linked streptavidin
were from Pierce Chemical Co. (Rockford, IL). Biotin-conjugated
anti rabbit IgG, methyl-b-cyclodestrin, glutathione, and all other
reagents, unless otherwise stated, were purchased from
Sigma–Aldrich (St. Louis, MI). Anti-RAGE-blocking antibody, which
blocks receptor-ligand interaction, was from RD System
(Minneapolis, MN, catalog number: AF1179). The src-specific
inhibitor pyrazolo pyrimidine-type inhibitor 1 (PP1) (Schindler
et al., 1999) was from Biomol (Plymouth Meeting, PA). S100
isolated from bovine brain, was obtained from Calbiochem (EMD
Biosciences, San Diego, CA, catalog number: 559284).
Biotinylation assay and biotin internalization assay
Primary SC were isolated from sciatic nerves of 3-day-old Harlan
Sprague–Dawley rats and cultured as described previously (Mikol
et al., 2002). The advantage of these cells is that they can be frozen
and re-cultured without losing their phenotype. Indeed, these cells
do not develop replicative senescence during culturing (Mathon
et al., 2001). Two different preparations were used for the
experiments described. Various aliquots from two different
preparations were de-frozen and cultured until passage 5.
Twenty-four hours before stimulation with S100 (20mg ml1), cells
were serum-starved in Schwann cell-defined medium (SCDM)
(50% DMEM, 50% Ham’s F12, 10 mg ml1 transferrin, 10 mM
putrescine, 20 nM progesterone, 30 nM sodium selenite). To
investigate the half-life of surface RAGE, cells were biotinylated
with NHS-LC biotin and processed as described previously
(Zurzolo et al., 1993; Perrone et al., 2005). After biotinylation, cells
were stimulated at 378C with bovine brain-derived S100, a
well-defined activator of RAGE (Hofmann et al., 1999; Vincent
et al., 2007). Cells were lysed in RIPA buffer. Biotinylated antigens
were pull-down with streptavidin-agarose beads. After boiling theJOURNAL OF CELLULAR PHYSIOLOGYbeads in Laemmli buffer, supernatants were analyzed by
SDS–PAGE and fluorography with preflashed films. To control the
total amount of RAGE, 1/10 of the supernatant was analyzed by
Western blotting. Densitometry was carried out within the linear
range of the films.
For endocytosis assay, cells were biotinylated using cleavable
biotin: sulphosuccinimidyl-6-(biotinamide) hexanoate
(NHS-SS-biotin) as described elsewhere (Perrone et al., 2005).
Samples were incubated at 378C for different times in the presence
of bovine brain S100, whereas control filters were kept at 48C.
After incubation, cells were lysed in RIPA buffer (10 mM Tris/Cl
pH 8, 1% TX-100, 0.1% DOC, 0.1% SDS, 140 mM NaCl, and 1 mM
PMSF). Biotinylated antigens were pulled-down with
streptavidin-agarose beads. After the beads were boiled in Laemmli
buffer, supernatants were analyzed by SDS–PAGE and
fluorography with preflashed films. To control the total amount of
RAGE, 1/10 of the supernatant was analyzed by Western blotting.
Densitometry was carried out within the linear range of the films.
Antibody-mediated internalization assay: receptor
clustering-mediated internalization
Antibody-mediated internalization is a technique that has been
extensively applied to investigate the endocytic fate of various
receptors and membrane-associated proteins (Tiruppathi et al.,
1997; Piazza et al., 2005; Millan et al., 2006; Tampellini et al., 2007).
Schwann cells were growth on glass coverslips coated with
1 mg ml1 poly-L-lysine and starved in SCDM for 24 h. Rabbit
anti-RAGE antibody (1 mg ml1) (H-300, Santa Cruz Biotechnology,
Inc., Santa Cruz, CA) was added to the SC for 30 min at 48C
in incubation medium (DMEM, 10 mM Hepes pH 7.5, 0.2% BSA).
The specificity of this antibody has been previously verified and it
has been employed to detect RAGE subcellular localization in
vesicles by co-localization experiments and immunofluorescence
analysis (Hermani et al., 2006). For internalization studies, cells
were fixed either immediately after incubation at 48C (0 min,
indicating surface labeled RAGE) or following incubation at 378C
for various times to induce the internalization of RAGE-antibody
complex (Tampellini et al., 2007). Indeed, the incubation of the cells
at 48C completely block the endocytic machinery and RAGE
ligands are not internalized (Schmidt et al., 1993). Briefly, cells were
washed twice with ice cold PBS containing 1.8 mM Ca2þ and 0.5 mM
Mg2þ (PBS/CM) to eliminate the unbound antibody, incubated at
378C in SCDM for different times, then washed twice with ice cold
PBS/CM and fixed for 20 min with 4% paraformaldehyde (PFA)
in PBS. To verify that in the absence of incubation at 378C the
antibody labels only surface RAGE, while it is internalized together
with RAGE following incubation at 378C, we performed a confocal
Z stack analysis (Tampellini et al., 2007). Control cells (0 min) and
cells incubated for 5 min at 378C were permeabilized (see below)
and the localization of the RAGE-antibody complex and
phosphorylated cav1 were investigated by immunofluorescence
and confocal analysis performing Z-stack sections from the bottom
of the cells (adhesion of the cells to the cover slips) to the top of the
cells. Optical sections were acquired at 0.7 mm thickness
(supplemental Figs. S1 and S2). For confocal analysis, cells were
treated for 5 min with PBS/CM containing 0.15% TX-100, blocked
with PBS/CM, 0.05% TX-100 and 1% bovine albumin for 30 min.
Cells were incubated at room temperature for 1 h with
biotin-conjugated anti rabbit IgG (1:400) (Sigma–Aldrich, catalog
number: B7389) and the appropriate antibody for the double
staining: mouse anti-phospho-cav-1 (1:25) (Tyr14 BD; BD
Transduction, BD Biosciences, catalog number 611338), mouse
anti-Rab11 (1:200) (BD Biosciences. Clone 47, catalog number
610656), mouse anti-S100 (1:100) (Chemicon, Millipore, Bilerica,
MA, catalog number MAB079-1). Fluorescein isothiocyanate
(FITC)-conjugated streptavidin and Texas-Red-conjugated
anti-mouse IgG were used for staining (Molecular Probes,
Invitrogen, Carlsbad, CA).
62 P E R R O N E E T A L .Lysosomes were detected by incubating the cells with
LysoTracker Red (1:10,000) (Molecular Probes, Invitrogen, catalog
number L-7528) 30 min before antibody-mediated RAGE
internalization. Specimens were mounted in ProLong gold
mounting medium containing DAPI (Invitrogen).
Analysis of immunofluorescence was performed with an
Olympus FluoView 500 laser scanning confocal microscope.
Samples were visualized with an Olympus IX-71 inverted
microscope using a 60 oil-immersion lens, magnified two times
with FluoView version 5.0 software and scanned sequentially to
maximize signal separation. DAPI, AlexaFluor 488 and AlexaFluor
594 fluorescence were excited with a 405 nm blue laser diode,
488 nm argon blue and 543 nm helium neon laser, respectively.
Emissions were separated with 430–460 nm, 505–525 nm, and
610þ nm barrier filters.
Immunofluorescence analysis after stimulation with
bovine brain S100
To obtain synchronous stimulation of surface RAGE, cells were
stimulated with bovine brain S100 at 48C for 30 min. Unbound S100
were washed with ice-cold PBS/CM, and cells were incubated at
378C for different times. Cells were fixed in 4% PFA in PBS/CM for
20 min. They were then washed twice with PBS/CM and once
with NH4Cl 5 mM in PBS/CM to quench the excess PFA. Cells were
permeabilized 5 min with TX-100 0.15% in PBS/CM and blocked for
30 min in PBS/CM containing 0.05% TX-100 and 1% BSA. Cells
were incubated for 1 h at room temperature with the primary
antibody: rabbit anti-dynamin (H-300) (1:100) (SantaCruz
Biotechnology, Inc., catalog number sc-11362); mouse anti-
phospho cav1 (1:25) (Tyr14 BD Transduction, BD Biosciences,
catalog number 611338). They were then washed three times for
10 min with PBS/CM and incubated for 1 h at room temperature
with the fluorochrome-labeled secondary antibody (Molecular
Probes, Invitrogen). The morphology of SC was examined under
the same conditions. Immunofluorescence was analyzed with an
Olympus FluoView 500 laser scanning confocal microscope as
described above.
Treatment with high glucose
To investigate the effect of high glucose on SC morphology, cells
were growth in 50 mM glucose for 24 h, serum-starved in 50 mM
glucose for an additional 24 h before stimulation.
Immunoprecipitation and immunoblot analysis
Cells were washed twice with ice-cold PBS/CM and lysed as
described elsewhere (Jori et al., 2003). Samples were
immunoprecipitated with the following antibodies: rabbit
anti-cav-1 1:100 (N-20, Santa Cruz Biotechnology, Inc., catalog
number sc-894), rabbit polyclonal anti-RAGE 1:100 (H-300, Santa
Cruz Biotechnology, Inc., catalog number sc-5563), mouse
anti-c-src 1:100 (Upstate/Millipore, catalog number 05-184).
Western blot analysis was carried out with the following
antibodies: mouse anti-phospho-cav-1 1:500 (Tyr14, BD
Transduction, catalog number 611338), rabbit anti-cav-1 1:1,000
(BD Transduction, catalog number 610406), mouse anti-RAGE
1:500 (RD Systems, catalog number MAB1179), mouse anti-S100B
1:1,000 (Chemicon, catalog number MAB079-1), HRP-conjugated
streptavidin 1:5,000 (Pierce Chemical Co., catalog number N200).
Rabbit anti-phospho Fak (Santa Cruz Biotechnology, Inc., catalog
number sc-16563-R), anti-Fak (BD Transduction, catalog number
610088). Rabbit anti phospho-src (1:1,000) (Calbiochem, EMD
Biosciences, catalog number 569373). Mouse anti-c-src 1:1,000
(Santa Cruz Biotechnology, Inc., catalog number sc-5266).
To inhibit RAGE-S100 interaction, cells were incubated with a
blocking antibody against rat RAGE (25 mg/ml) (RD System
Minneapolis, MN, catalog number: AF1179) for 30 min at 48C. Cells
were then treated with bovine-brain S100 20 mg/ml at 378C.
Anti-RAGE blocking antibodies from RD System were previouslyJOURNAL OF CELLULAR PHYSIOLOGYused to inhibit the interaction of RAGE with the ligand (Hermani
et al., 2006; Sakaguchi et al., 2008). The blocking antibody is not
suitable for immunofluorescence analysis as indicated by the
manufacturer instruction and a previous report (Hermani et al.,
2006).
Results
RAGE is internalized and recycles at the plasma
membrane after stimulation with S100
To correlate the endocytic trafficking of RAGE with its
physiological function in SC, we analyzed the endocytic
trafficking of endogenous RAGE in primary cultures of SC. To
determine whether RAGE is degraded or recycles to the plasma
membrane after S100 stimulation, we used an endocytosis assay
based on the use of a cleavable biotin analog (Perrone et al.,
2005). After biotinylation, SC were treated with bovine brain
S100 (20mg/ml), a well-defined RAGE activator (Hofmann et al.,
1999; Vincent et al., 2007), for 0, 5, 20, and 60 min in duplicate.
The sample treated with glutathione shows whether the
receptor is endocytosed because internalized receptor is not
accessible to glutathione. The sample not treated with
glutathione represents the total amount of biotinylated
receptor during stimulation. After stimulation with S100 for
5 and 20 min, biotinylated RAGE was in an endocytic
compartment (Fig. 1A, lanes 3–6). After 60 min of stimulation,
biotinylated RAGE was again available for glutathione cleavage,
whereas the total amount of biotinylated RAGE was reduced by
only 20% (Fig. 1A, lanes 7, 8). Thus, about 80% of RAGE recycles
at the plasma membrane after 60 min of S100 stimulation.
Biotinylation does not affect RAGE subcellular localization or
signaling either under steady-state conditions or upon
stimulation with S100 (data not shown).
We next analyzed the half-life of RAGE with and without
S100 stimulation. Schwann cells were treated with
cycloheximide (CHX, 50 mg/ml) and incubated with and
without S100. In the absence of S100, RAGE decreased after 3 h
of incubation with CHX and was greatly reduced after 16 h
(Fig. 1B, lanes 5 and 6). On the contrary, RAGE was unvaried up
to 16 h of incubation with CHX in the presence of S100
(Fig. 1B, lanes 1–4).
We monitored the endocytic trafficking of RAGE using
antibody ligation-induced internalization (Tiruppathi et al.,
1997; Piazza et al., 2005; Millan et al., 2006; Tampellini et al.,
2007). The anti-RAGE antibody used in this assay induces both
the internalization (Fig. 1C) and signaling of RAGE (Fig. 2A, lane
4). Cells were incubated 30 min at 48C with anti-RAGE
antibody, washed and incubated at 378C for 5 min. Internalized
RAGE was targeted to a perinuclear compartment and
co-localized with Rab11 after 5 min of incubation at 378C
(Fig. 1C). After stimulation with S100 both internalized RAGE
and Rab11 were localized in the perinuclear compartment,
whereas in the absence of S100, RAGE was distributed over the
whole cell surface (Fig. 1C). Internalized RAGE did not
co-localize with lysosomes (data not shown). These data
demonstrate that RAGE is targeted to the recycling pathway
after interaction with the ligand.
Src-mediated phosphorylation of cav-1 is required for
RAGE recycling at the plasma membrane
Phosphorylated cav-1 is involved in endocytic trafficking
(Tiruppathi et al., 1997; del Pozo et al., 2005). Since RAGE
activation results in src-mediated phosphorylation of cav-1 in
endothelial smooth muscle cells (Reddy et al., 2006), we sought
to examine whether stimulation of RAGE induces src-mediated
cav1 phosphorylation in SC. Src was activated after 5 min
of treatment with bovine brain S100 (Fig. 2A, lane 2). Src
activation was RAGE-dependent. Indeed, a RAGE-blocking
antibody strongly reduced S100-induced src activation
Fig. 1. RAGE is targeted to the recycling pathway upon stimulation. A: SC were surface biotinylated with NHS-SS-biotin and then incubated at
37-C with bovine brain S100 (20 mg ml1). Biotinylated and total RAGE were detected by Western blotting. Quantification of three
independent experiments is shown at the bottom of the figure. B: SC were treated with cycloheximide (15 mg/ml) and S100 (20 mg ml1) as
indicated.RAGEwasdetectedbyWesternblotting.Quantificationofthreeindependentexperimentsisshownatthebottomofthefigure.C:RAGE
internalization (green) was induced by antibody-mediated internalization. The localization of internalized RAGE (green) and Rab11 (red) was
evaluated by immunofluorescence and confocal analysis. The scale bar indicates 10 mm. These experiments are representative of at least three
independent experiments. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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S100-mediated src phosphorylation (Fig. 2A, lane 5). RAGE
triggering by an antibody against the extracellular domain of
RAGE also induced src phosphorylation, which confirms that
src-induction is RAGE-dependent (Fig. 2A, lane 4).
We next investigated whether RAGE activation induces
cav-1 phosphorylation. Cav-1 phosphorylation increased
fourfold after 5 min of stimulation with bovine brain S100
(Fig. 2B, compare lanes 1 and 2). Cav1 phosphorylation was
src-dependent. Indeed, the src-specific inhibitor PP1 (Khan
et al., 2006) totally abolished S100-mediated cav1
phosphorylation (Fig. 2B, lane 3). The antibody against the
extracellular domain of RAGE also increased cav1
phosphorylation sixfold thereby demonstrating that RAGE
triggering induces cav1 phosphorylation (Fig. 2B, lane 4). To
assess whether phosphorylated cav1 is involved in RAGEJOURNAL OF CELLULAR PHYSIOLOGYendocytic trafficking, we investigated the localization of
phosphorylated cav1 and RAGE by antibody ligation-induced
internalization. RAGE did not co-localize with phospho-cav-1 in
the absence of activation at 378C (Fig. 2C), whereas internalized
RAGE co-localized with phospho-cav-1 in a perinuclear
compartment after 5 and 20 min of incubation at 378C (Fig. 2C).
Phosphorylated cav1 was relocated in the perinuclear
compartment after RAGE activation, whereas it was localized
exclusively at the plasma membrane in the absence of RAGE
triggering (Fig. 2C). RAGE and phosphorylated cav1
co-localized in a perinuclear region also after stimulation with
bovine brain S100 (data not shown). Confocal Z stack images
demonstrate that endocytosis of surface RAGE does not occur
at 48C. Indeed, the uptake of anti-RAGE antibody is blocked
when cells are fixed at 0 min. Following permeabilization of the
cells, the staining of RAGE-antibody complex is evident only in
ig. 2. Phosphorylated cav-1 targets RAGE to the recycling pathways. A: SC were stimulated with S100 (20mg ml1) for the indicated time with
nd without an anti-RAGE blocking antibody (BL Ab), anti-RAGE activating antibody, or unspecific IgG. Protein extracts were immunoprecipitated
ithamouseanti-srcantibody.PhosphorylatedsrcandsrcweredetectedbyWesternblotting.Quantificationofthreeindependentexperimentsis
hown at the bottom of the figure. B: SC were stimulated as in (A). Protein extracts were immunoprecipitated with an anti-cav1 antibody.
hosphorylatedcav1andcav1weredetectedbyWesternblotting. Quantification of three independent experiments is shownatthe bottom of the
gure. C: Internalization of RAGE (green) was induced by antibody-mediated internalization and incubation at 37-C for the indicated times.
ternalized RAGE (green) and phosphorylated cav-1 (red) were detected by immunofluorescence and confocal microscopy. The scale bar
dicates 10mm. Bl Ab U anti-Rage blocking antibody. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.
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co-localize with phosphorylated cav1 in any of the Z-scan
sections (supplemental Fig. S1). Incubation at 378C for 5 min
leads to relocation of RAGE-antibody complex to the
intracellular compartment, as demonstrated by confocal Z scan
images following permeabilization of the cells. There is no
evident staining of RAGE-antibody complex at the plasma
membrane (top sections), while it is localized in an intracellular
compartment where it co-localizes with phosphorylated cav-1
(supplemental Fig. S2). In the absence of cell permeabilization,
the staining of RAGE-antibody complex is evident at 0 min,
while it is strongly reduced following 5 min of incubation at
378C (data not shown). Since after incubation at 378C the
staining of RAGE-antibody complex is evident only following
permeabilization of the cells, we further demonstrate that the
uptake of anti-RAGE antibody is blocked at 48C and that RAGE-
antibody complex is internalized following incubation at 378C.
We next investigated whether phosphorylation of cav-1
plays a functional role in RAGE endocytic trafficking. To this
aim, cells were pre-treated with 5 mM PP1 for 45 min to inhibit
src-mediated cav-1 phosphorylation (Khan et al., 2006). This
experiment confirmed that RAGE recycles at the plasma
membrane after 60 min of stimulation with bovine brain S100
(Fig. 3A, lanes 1–4). Biotinylated RAGE was greatly reduced in
the presence of PP1 and glutathione cleavage (about 85%
compared with control time 0 min without glutathione
cleavage). It was also greatly reduced in the presence of PP1 and
in the absence of glutathione cleavage (about 80% compared
with control time 0 min), suggesting that src-inhibition induces
RAGE degradation after S100 stimulation. We used
biotinylation-based degradation assays (Jullien et al., 2002;
Tanowitz and Von Zastrow, 2002; Chen et al., 2005; Tampellini
et al., 2007) to determine whether inhibition of src activation
changes the trafficking fate of RAGE. Cells were biotinylated
and stimulated with bovine brain S100 at 378C for different
times in the presence and absence of PP1. Without PP1,
biotinylated RAGE was reduced (by about 30%) after 3 h of S100
stimulation. On the contrary, in the presence of PP1,
biotinylated RAGE was reduced by about 72% after 1 h of S100
stimulation (Fig. 3B). Using antibody-cross linking-mediated
internalization, we found that RAGE is targeted to lysosomes
after 30 min of S100 stimulation in the presence of PP1 (Fig. 3C).
We then examined the localization of internalized RAGE and
Rab11 after 5 min of antibody-cross linking-mediated
internalization both with and without PP1-induced src
inhibition. We observed a reduction of RAGE-Rab11
co-localization in the presence of PP1 compared to the control
stimulated in the absence of PP1 (Fig. 3D).
Accordingly, the endocytosis assay showed that about
20% of biotinylated RAGE recycles at the plasma membrane
(Fig. 3A). These data demonstrate that inhibition of src changes
the trafficking fate of internalized RAGE. Indeed, in the
presence of PP1, about 80% of RAGE was targeted for
degradation, whereas only 20% was still targeted to the
recycling pathway.
RAGE-induced secretion of S100B requires src activation
Although RAGE induces S100B relocation in vesicles in
endothelial cells (Hsieh et al., 2004), the trafficking pathway
responsible for S100B translocation in vesicles is unknown.
Since SC express endogenous S100B, we investigated whether
RAGE triggering affects S100B exocytic trafficking using the
antibody-mediated internalization assay. As shown in
Figure 4A, RAGE and S100B did not co-localize in the absence of
induction of endocytosis by incubation of the cells at 378C (time
0-min in Fig. 4A). Internalized RAGE co-localized with S100B in
vesicle-like structures in the perinuclear region upon 5 min
of internalization at 378C. RAGE and S100B still co-localizedJOURNAL OF CELLULAR PHYSIOLOGYafter 20 and 60 min of internalization and were distributed
throughout the cytoplasm. The relocalization of S100B in
vesicles was mediated by RAGE triggering. Indeed, in cells
treated with an unspecific IgG and incubated at 378C for 5 min,
no vesicles were S100B-positive, whereas S100B appeared in
the cytoplasm.
PP1 inhibited RAGE co-localization with endogenous
S100B (Fig. 4B). S100B and internalized RAGE were localized in
a perinuclear compartment after 60 min of RAGE triggering in
the presence of PP1; however, the co-localization was very low
and S100B and RAGE staining was weak (Fig. 4B). S100B
relocation in vesicles is Ca2þ-dependent in astrocytoma cells
(Mbele et al., 2002). RAGE triggering in the presence of 10 mM
EGTA inhibited S100B co-localization with RAGE (data not
shown), which is in agreement with a previous finding (Davey
et al., 2001).
We also investigated the RAGE-S100B association in
co-immunoprecipitation experiments using an anti-RAGE
antibody. Stimulation with exogenous bovine brain S100 greatly
increased the amount of S100B in the immunocomplex (about
sevenfold induction compared with unstimulated cells)
(Fig. 4C, lane 2). Although we do not know whether RAGE
co-immunoprecipitates with endogenous or extra-cellular
S100B or both, this observation could suggest that RAGE does
not dissociate from extracellular S100. In agreement, RAGE is
responsible for the transcytosis of the b-amyloid peptide from
the apical to the basolateral surface in endothelial cells, further
demonstrating that RAGE does not dissociate from the ligand
during its endocytic trafficking (Mackic et al., 1998).
Astrocytes secrete S100B consequent to metabolic stress
(Gerlach et al., 2006). Since SC express endogenous S100B, we
sought to determine whether RAGE activation induces
secretion of endogenous S100B. To this aim, we stimulated
RAGE using antibody-mediated internalization to identify
endogenous S100B in the media, and used Western blotting to
evaluate S100B secretion after tri-fluoro acetic acid (TCA)
precipitation of the culture medium (Pachydaki et al., 2006). To
quantify the cell number stimulated in the different conditions,
we measured the amount of actin by Western blot
(Fig. 4D, bottom). S100B was not detectable in the media in the
absence of stimulation or after 20 min of RAGE triggering,
whereas it was secreted after 60 and 120 min of RAGE
triggering (Fig. 4D, lanes 1–4). S100B secretion was src-
dependent and was completely abolished in the presence of PP1
(Fig. 4D, lane 5). Treatment of SC with PP1 in the presence of an
unrelated antibody instead of anti-RAGE antibody did not
induce S100B secretion (Fig. 4D, lane 6), which confirms that
RAGE triggering is required for S100B secretion.
High glucose inhibits RAGE-induced src activation
RAGE plays a key role in the development of diabetes (Bierhaus
et al., 2005). However, the effect of a HG concentration on
RAGE function in SC is unknown. In an attempt to shed light on
this issue, we first analyzed the effect of HG on RAGE-mediated
src activation after S100 stimulation. In culture medium with a
physiological glucose concentration (5.5 mM¼ LG), src was
activated in response to S100 stimulation, whereas 50 mM
glucose (HG) inhibited RAGE-mediated src activation to the
same extent as PP1 (Fig. 5A lanes 1–4, and 6). High glucose did
not affect src phosphorylation in the absence of S100
stimulation (Fig. 5A, lane 5), neither did it affect cell viability
(data not shown). We next investigated Fak phosphorylation
after RAGE triggering. Fak activation was delayed despite src
phosphorylation; it occurred after 10 min of RAGE triggering
and persisted up to 15 min of stimulation (Fig. 5B, lanes 1–4).
Inhibition of src activation with PP1 completely abolished Fak
phosphorylation (Fig. 5B, lane 5). High glucose also inhibited
RAGE-mediated Fak activation (Fig. 5B, lane 6). It did not affect
Fig. 3. src activation isnecessary for RAGE recycling at the plasma membrane. A:SC were incubated with src-specific inhibitor PP1. Control and
PP1-treated cells were surface biotinylated with NHS-SS-biotin and incubated at 37-C with S100 (20mg ml1) for the indicated times. Biotinylated
RAGE was detected by Western blotting after pull-down with avidin beads (top). Total RAGE was analyzed by Western blotting. Quantification of
three independent experiments is shown at the right of the figure. B: Cells were surface biotinylated with NHS-LC-biotin and incubated at 37-C
withS100 (20mg ml1) for the indicated times. Biotinylated RAGEwasdetected byWesternblottingafterpull-downwith avidin beads (top).Total
RAGEwasevaluatedbyWesternblotting.Quantificationof three independentexperiments is shownattherightof thefigure.C: Internalizationof
RAGE (green) was induced by antibody-mediated internalization. Cells were incubated at 37-C for 30 min with PP1. Control cells were fixed
immediatelyafterantibody-mediatedRAGEinternalization.LysosomesweredetectedbyincubatingthecellswithLysotraker(red).Thescalebar
indicates10mm.D: InternalizationofRAGEwascarriedoutas in(C)bothwithandwithoutPP1.The localizationof internalizedRAGE(green)and
Rab11 (red) was evaluated with immunofluorescence and confocal microscopy. These experiments are representative of at least three
independent experiments. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
JOURNAL OF CELLULAR PHYSIOLOGY
Fig. 4. InternalizedRAGEco-localizeswithendogenousS100B.A,B: InternalizationofRAGEwas inducedbyantibody-mediated internalization.
The localizationof internalizedRAGE(green)andS100B(red)wasevaluatedwith immunofluorescenceandconfocalmicroscopy.Ascontrol, cells
were treated with unspecific IgG instead of with anti-RAGE antibody and incubated at 37-C for 5 min (bottom). B: RAGE internalization was
carried out as in (A). Cells were treated with PP1. The localization of internalized RAGE (green) and S100B (red) was evaluated with
immunofluorescence and confocal microscopy. The scale bar indicates 10 mm. C: SC were stimulated with S100 for 20 min. Protein extracts were
immunoprecipitated using an anti-RAGE antibody. S100B and RAGE were detected by Western blotting. Quantification of three independent
experiments is shown at the bottom of the figure. D: Internalization of RAGE was induced by antibody-mediated internalization both in the
presence and absence of PP1. As control, cells were incubated with unspecific IgG instead of anti-RAGE antibody and incubated at 37-C in the
presence of PP1. Cells were incubated with fresh medium after antibody-mediated RAGE internalization. The medium was collected at the
indicated time and was precipitated using TCA. The presence of S100B was evaluated with Western blotting. The amount of actin was evaluated
with Western blotting as a control of the number of cells stimulated. These experiments are representative of at least three independent
experiments. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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(Fig. 5B, lane 7). This is in line with the finding that HG inhibits
Fak activation in rat peritoneal mesothelial cells (Tamura
et al., 2003).JOURNAL OF CELLULAR PHYSIOLOGYPhosphatidylinositol 3-kinase (PI3K) activation induces Fak
phosphorylation in SC (Cheng et al., 2000). We therefore
investigated whether the PI3 kinase pathway is involved in
RAGE-mediated Fak phosphorylation. The PI3K inhibitor
Fig. 5. HGinhibitsS100-inducedsrcandFakphosphorylation.A:SCwerestimulatedwithS100(20mg ml1) fortheindicatedtime.PP1wasadded
as indicated. Cells were treated with HG (50 mM) for 48 h and during the stimulation where indicated. Protein extracts were immunoprecipitated
with a mouse anti-src antibody. Phosphorylated src and src were detected by Western blotting. Quantification of three independent
experiments is shown at the right of the figure. B: SC were stimulated as in A. Phosphorylated Fak and Fak were detected by western blotting.
Quantificationofthreeindependentexperimentsisshownattherightofthefigure.C:PI3KinhibitorLY294002(10mM)wasaddedwhereindicated.
PhosphoFakandFakweredetectedbyWesternblotting.Quantificationofthreeindependentexperimentsisshownattherightofthefigure.These
experiments are representative of at least three independent experiments.
68 P E R R O N E E T A L .LY294002 completely blocked Fak phosphorylation in response
to S100 stimulation (Fig. 5C, lane 3), whereas LY294002 did not
affect Fak phosphorylation in the absence of stimulation with
S100 (Fig. 5C, lane 4).
HG inhibits S100-induced phospho-cav1 and
dyn2 co-localization and SC morphological changes
Since dynamins are involved in phosphorylated cav1-mediated
endocytosis (del Pozo et al., 2005), we investigated the
subcellular localization of dynamins after S100 stimulation. We
incubated SC for 30 min with S100 at 48C. Cells were then
washed and incubated at 378C for 30 sec and 5 min.
Phosphorylated cav1 and dynamin did not co-localize in the
absence of S100 stimulation (Fig. 6A). Phosphorylated cav1 was
localized at the plasma membrane after 30 sec of stimulation,
whereas dynamin showed filament-like structures in theJOURNAL OF CELLULAR PHYSIOLOGYcytoplasm (Fig. 6A). Interestingly, after 30 sec of stimulation,
dynamin co-localized with phospho-cav1 only in one site at the
plasma membrane, suggesting that remodeling of the adhesion
occurs at this site (Fig. 6A). Phosphorylated cav1 co-localized
with dynamin in a perinuclear compartment after 5 min of
S100 stimulation (Fig. 6A). High glucose inhibited the
perinuclear localization of phosphorylated cav1 after 5 min
of S100 stimulation as well as its co-localization with dynamin
(Fig. 6A). Compared with control cells, HG did not affect
phosphorylated cav1 in the absence of stimulation with
S100 (Fig. 6A).
We previously reported that morphological changes of
neuroblastoma stem cells correlate with cellular differentiation
(Jori et al., 2001). Given our present observation that RAGE
induces Fak activation, and the finding that Fak activation is
involved in SC motility (Cheng et al., 2000), we analyzed
RAGE-mediated changes in SC shape. To this aim, we incubated
Fig. 6. HG inhibits S100-induced SC morphological changes. A: SC
were stimulated with S100 (20mg ml1) at 4-C for 30 min, washed and
incubated at 37-C for the indicated time. HG (50 mM) was added as
indicated. As a control, SC were incubated with HG in the absence of
S100 (bottom). The intracellular localization of phosphorylated cav1
(red) and dyn2 (green) was analyzed by indirect immunofluorescence
and confocal microscopy. B: SC were stimulated as in (A). Changes
in cell shape were analyzed by phase contrast microscopy. These
experiments are representative of at least three independent
experiments. LG U low glucose; HG U high glucose. [Color figure can
be viewed in the online issue, which is available at www.interscience.
wiley.com.]
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removing unbound S100 by washing, we incubated the cells for
30 min at 378C. Cells were fixed in 4% PFA and we examined
their morphology by phase-contrast microscopy. Schwann cells
acquired their characteristic bipolar shape after stimulation
with S100, whereas they had a flattened fibroblast-like shape in
the absence of S100 stimulation (Fig. 6B, top). High glucose
partially inhibited the bipolar shape induced by S100. Indeed, in
the presence of S100 and a HG concentration, SC started to
elongate and to acquire the bipolar shape, although they
retained a flat fibroblast-like morphology (Fig. 6B, bottom
right). Without S100 stimulation and under HG conditions, SC
assumed a fibroblast-like shape (Fig. 6B, bottom left).JOURNAL OF CELLULAR PHYSIOLOGYDiscussion
A previous study suggests that SC-mediated S100B secretion is
required for peripheral nerve regeneration. Indeed, antibodies
against S100B block peripheral nerve regeneration in vivo
(Rong et al., 2004a). However, SC-mediated S100B secretion is
still poorly investigated. SC are known to secrete a 12-kDa
protein that induces neurite outgrowth in PC12 cells (Bampton
and Taylor, 2005). In this report we demonstrate for the first
time that SC secrete S100B. Also glioblastoma cells (Davey
et al., 2001) and astrocytes (Gerlach et al., 2006) secrete S100B.
However, the molecular mechanisms governing S100B
secretion are still poorly understood. Several lines of evidence
previously suggested that RAGE might be involved in the
relocation in vesicles of various S100 family proteins. Indeed,
stimulation of prostate cancer cells with the RAGE ligands
S100A8/9 induced the co-location of RAGE with S100A8/9 in
vesicles (Hermani et al., 2006). In endothelial cells, translocation
of endogenous S100 proteins in vesicles is RAGE-dependent
(Hsieh et al., 2004). The addition of exogenous S100A13
induced RAGE co-localization with endogenous S100A13, and
pre-treatment with soluble RAGE inhibited S100A13
relocation in vesicles, which suggested that RAGE is required
for S100A13 internalization and relocation of endogenous
S100A13 in vesicles (Hsieh et al., 2004). However, neither
RAGE internalization nor S100A13-RAGE co-localization was
demonstrated. We provide the first demonstration that RAGE
triggering induces RAGE internalization and the fusion of
RAGE-containing endocytic vesicles with S100B-positive
secretory vesicles (see model shown in Fig. 7A). Relocation of a
specific S100 protein in vesicles was found to occur only when
RAGE was stimulated with the same extracellular S100 protein,
whereas it was inhibited by stimulation with a different member
of S100 family (Hsieh et al., 2004). We show that triggering of
RAGE with an anti-RAGE antibody induces S100B relocation in
RAGE-positive endocytic vesicles. It is conceivable that
different S100 proteins interact with specific proteins thereby
activating specific trafficking pathways and inhibiting the
translocation in vesicles of another member of the S100 protein
family. Anti-RAGE antibody does not induce this effect. Here
we demonstrate that anti-RAGE antibody induces RAGE
internalization and signaling, as well as co-localization of
internalized RAGE with endogenous S100B, which results in
secretion of S100B. We also show that RAGE recycling
correlates with S100B secretion. Indeed, as shown in
Figure 7A, src orchestrates a hitherto unknown vesicular
pathway that leads to RAGE recycling at the plasma membrane,
fusion with S100B-containing vesicles, and S100B secretion.
Inhibition of src activation leads to RAGE degradation and
inhibits RAGE-S100B co-localization in vesicles as well as S100B
secretion. In agreement with our model, it has been shown that
RAGE triggers the internalization and the transcytosis of the
Amyloid-b 1–40 peptide from the apical to the basolateral
membrane in endothelial cells (Mackic et al., 1998). Indeed,
Mackic et al. (1998) demonstrate that the degradation of the
amyloid peptide is very low in endothelial cells, further
supporting that internalized RAGE is not targeted to
lysosomes. Eventual differences in the quantification of b-
amyloid transcytosis in endothelial cells and RAGE recycling in
SC can be due to the different methods used to investigate
RAGE trafficking and/or the different cell type analyzed. In our
experiments SC are not polarized, so we cannot evaluate
whether RAGE is targeted to a transcytotic pathway. However,
in agreement with our data in correlation with the Mackic et al.
(1998) report, it has been demonstrated that src, cav-1 and dyn
play a role in caveolae-mediated transendothelial transport
(Shajahan et al., 2004a,b). Furthermore, RAGE co-fractionates
with caveolae-rich membrane in endothelial cells (Lisanti et al.,
1994) and we found that RAGE is lipid rafts associated and
Fig. 7. Model for the autocrine stimulation of SC induced by RAGE
triggering. A: Activation of RAGE induces src-mediated
phosphorylation of cav-1 that targets RAGE to the recycling pathway
in Rab11-positive vesicles. Internalized RAGE is targeted to vesicles
containing endogenous S100B, which is secreted in response to RAGE
activation. B: RAGE triggering induces src-mediated cav1
phosphorylation and re-location in the perinuclear compartment
together with dyn2. Src orchestrates RAGE recycling, S100B
secretion and morphological changes.
70 P E R R O N E E T A L .interact with cav-1 in SC (data not shown). Interestingly, the
endocytic pathway here described for RAGE has been
previously demonstrated for the gp60 receptor. Indeed,
interaction of gp60 with either albumin or a gp60-specific
antibody leads to src and cav-1 phosphorylation and induces
gp60 internalization and targeting to the transcytotic pathway in
endothelial cells (Tiruppathi et al., 1997). Further supporting
our data compared with the Mackic et al. (1998) study, the
function of Rab11 in transcytosis has also been demonstrated
(Ducharme et al., 2007). Here we show that src-mediated
phosphorylation of cav-1 is necessary for RAGE recycling at
plasma membrane, while inhibition of src activation leads to
RAGE targeting to lysosomes. The function of src-mediated
phosphorylation of cav-1 in inhibiting receptor degradation and
promoting a perinuclear targeting has been previously
described for the EGF receptor (EGFR) (Khan et al., 2006).
Indeed, it is well described that EGFR can follow two alternate
pathways: be targeted to lysosomes for degradation or be
transported to a perinuclear compartment via caveolae (Khan
et al., 2006). Thus, the previous literature strongly support our
observations summarized in Figure 7A. However, here we
describe for the first time the role of cav-1 phosphorylation in
the endocytic trafficking of RAGE and its function in promoting
S100B secretion.JOURNAL OF CELLULAR PHYSIOLOGYHere we show that RAGE triggering induces plasma
membrane rearrangements. In agreement, S100B-mediated
RAGE activation induces cell motility (Reddy et al., 2006).
Receptor recycling and redistribution of membrane proteins
play a role in cell motility (Jones et al., 2006). Indeed, we
demonstrate that RAGE recycles through he Rab11 pathway.
RAGE triggering induces phosphorylated cav1 translocation to
the perinuclear compartment and co-localization with dynamin.
Our data are in line with the finding that the dyn2 and Rab11
pathways contribute to cell migration (Jones et al., 2006).
Changes of cell shape require a coordinate disassembly and
assembly of focal adhesions (Kruchten and McNiven, 2006).
Interestingly, increment of cav1 phosphorylation inhibits Fak
and causes disassembly of the actin cytoskeleton in
(myo)fibroblasts (Swaney et al., 2006). In agreement, we
demonstrate that phosphorylation of cav-1 is required for
RAGE recycling, suggesting that RAGE-mediated src activation
and subsequent cav-1 phosphorylation are responsible for
S100-mediated SC morphological changes. Indeed, inhibition
of src activation by high glucose treatment abolishes
S100-mediated morphological changes of SC.
Our study shows that changes in SC shape correlate with
S100B relocation in vesicles and S100B secretion. In agreement
with this finding, relocation of S100B in vesicle-like structures
correlates with membrane rearrangements in astrocytoma
cells (Mbele et al., 2002). As shown in Figure 7B, we hypothesize
a model whereby RAGE first induces an increase of cav1
phosphorylation thereby leading to disassembly of the focal
adhesions. Next, perinuclear translocation of phosphorylated
cav1 leads to rearrangement of focal adhesions. Indeed,
endocytic trafficking of RAGE induces rearrangements of the
plasma membrane. In the presence of S100, SC acquire the
characteristic bipolar shape (Caddick et al., 2006), and show a
differentiated-like phenotype with a reduction of the cytoplasm
(Previtali et al., 2003). Changes in cell shape and cytoskeleton
rearrangements are required to acquire the differentiate SC
phenotype necessary to induce myelination (Previtali et al.,
2003). SC myelinating phenotype is characterized by the
expression of fibronectin (Akassoglou et al., 2002). We found
that S100-mediated RAGE activation induces the mRNA
expression of fibronectin (data not shown). Schwann cells,
RAGE and S100 are required for peripheral nerve regeneration
(Rong et al., 2004a,b; Dobrowsky et al., 2005). In agreement
with our data, src is activated in SC after rat peripheral nerve
injury (Zhao et al., 2003). We suggest that RAGE plays a key
function in SC modifications that are important during
regeneration of injured nerves.
We also demonstrate that HG inhibits RAGE-mediated src
phosphorylation. Moreover, RAGE-mediated changes in SC
shape do not occur under HG conditions. Given the
involvement of src in cell motility (Cutrupi et al., 2000), this
finding supports the concept that RAGE-mediated src
activation plays a role in changes in SC shape. We demonstrate
that inhibition of src activation induces RAGE degradation and
blocks S100B secretion. In line with this observation, HG
inhibits S100B secretion in astrocytes (Nardin et al., 2007).
Further support for the physiological relevance of our data
comes from the finding that regeneration of the injured sciatic
nerve is delayed or fails in diabetes (Zochodne et al., 2007).
Moreover, HG induces abnormal SC proliferation leading to a
not differentiated phenotype that is characteristic of diabetic
neuropathy (Almhanna et al., 2002). In agreement with these
observations, we found that HG inhibits RAGE-induced
fibronectin expression (data not shown).
In summary, we have identified a new vesicular pathway of
RAGE recycling and S100B secretion, thereby providing insights
into the role of RAGE in acquiring a pro-myelinating phenotype,
while high glucose abolishes RAGE mediated effects on SC by
inhibiting src activation.
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